CL:0000236

Name:	B cell
Namespace:	FANTOM
Definition:	"A lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity." [GO_REF:0000031, GOC:add, GOC:tfm, ISBN:0781735149]
Xrefs:	Expandlinks: BTO:0000776 FMA:62869
Synonyms:	"B lymphocyte" EXACT [] "B-cell" EXACT [] "B-lymphocyte" EXACT []

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000945(lymphocyte of B lineage)
develops_from:	CL:0000826(pro-B cell)

Children

is a:	CL:0000785 (mature B cell),CL:0000817 (precursor B cell),CL:0000818 (transitional stage B cell)
derives from:	FF:0000025 (CD19-positive B cell sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 10534-107G3 (acute lymphoblastic leukemia (B-ALL) cell line:NALM-6)
• 10631-108I1 (diffuse large B-cell lymphoma cell line:CTB-1)
• 11544-120B5 (CD19+ B Cells, donor1)
• 11624-122B4 (CD19+ B Cells, donor2)
• 11705-123B4 (CD19+ B Cells, donor3)
• 11856-125A2 (Mouse CD19+ B Cells, donor1)
• 12151-128F9 (CD19+ B Cells (pluriselect), donor090325, donation1)
• 12174-128I5 (CD19+ B Cells (pluriselect), donor090325, donation2)
• 12189-129B2 (CD19+ B Cells (pluriselect), donor090309, donation1)
• 12194-129B7 (CD19+ B Cells (pluriselect), donor090309, donation2)

... further results Mouse (Mus musculus)

• 10534-107G3 (acute lymphoblastic leukemia (B-ALL) cell line:NALM-6)
• 10631-108I1 (diffuse large B-cell lymphoma cell line:CTB-1)
• 11544-120B5 (CD19+ B Cells, donor1)
• 11624-122B4 (CD19+ B Cells, donor2)
• 11705-123B4 (CD19+ B Cells, donor3)
• 11856-125A2 (Mouse CD19+ B Cells, donor1)
• 12151-128F9 (CD19+ B Cells (pluriselect), donor090325, donation1)
• 12174-128I5 (CD19+ B Cells (pluriselect), donor090325, donation2)
• 12189-129B2 (CD19+ B Cells (pluriselect), donor090309, donation1)
• 12194-129B7 (CD19+ B Cells (pluriselect), donor090309, donation2)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000236 (B cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
3.42e-143	FFCP PHASE1:Hg19::chr11:58869930..58869933,-	p@chr11:58869930..58869933, -
3.42e-143	FFCP PHASE2:Hg19::chr11:58869930..58869933,-	p@chr11:58869930..58869933, -
5.72e-141	FFCP PHASE1:Hg19::chr11:82774371..82774374,-	p@chr11:82774371..82774374, -
5.72e-141	FFCP PHASE2:Hg19::chr4:102879640..102879645,+	p@chr4:102879640..102879645, +
5.72e-141	FFCP PHASE2:Hg19::chr11:82774371..82774374,-	p@chr11:82774371..82774374, -
5.72e-141	FFCP PHASE1:Hg19::chr4:102879640..102879645,+	p@chr4:102879640..102879645, +
6.53e-141	FFCP PHASE1:Hg19::chr2:231313038..231313049,+	p@chr2:231313038..231313049, +
6.53e-141	FFCP PHASE1:Hg19::chr6:32575596..32575598,-	p@chr6:32575596..32575598, -
6.53e-141	FFCP PHASE2:Hg19::chr6:32575596..32575598,-	p@chr6:32575596..32575598, -
6.53e-141	FFCP PHASE2:Hg19::chr2:231313038..231313049,+	p@chr2:231313038..231313049, +
1.35e-139	FFCP PHASE1:Hg19::chr10:5882480..5882508,+	p@chr10:5882480..5882508, +
1.35e-139	FFCP PHASE2:Hg19::chr10:5882480..5882508,+	p@chr10:5882480..5882508, +
2.14e-139	FFCP PHASE1:Hg19::chr19:42385114..42385126,+	p@chr19:42385114..42385126, +
2.14e-139	FFCP PHASE2:Hg19::chr19:42385114..42385126,+	p@chr19:42385114..42385126, +
8.11e-139	FFCP PHASE1:Hg19::chr9:37034277..37034297,+	p@chr9:37034277..37034297, +
8.11e-139	FFCP PHASE2:Hg19::chr9:37034277..37034297,+	p@chr9:37034277..37034297, +
1.18e-134	FFCP PHASE2:Hg19::chr6:89324309..89324332,-	p@chr6:89324309..89324332, -
1.18e-134	FFCP PHASE1:Hg19::chr6:89324309..89324332,-	p@chr6:89324309..89324332, -
6.0e-134	FFCP PHASE2:Hg19::chr3:112178705..112178716,-	p@chr3:112178705..112178716, -
6.0e-134	FFCP PHASE1:Hg19::chr3:112178705..112178716,-	p@chr3:112178705..112178716, -
2.29e-130	FFCP PHASE1:Hg19::chr9:82847043..82847053,+	p@chr9:82847043..82847053, +
2.29e-130	FFCP PHASE2:Hg19::chr9:82847043..82847053,+	p@chr9:82847043..82847053, +
5.01e-127	FFCP PHASE2:Hg19::chr9:37034351..37034358,+	p@chr9:37034351..37034358, +
5.01e-127	FFCP PHASE1:Hg19::chr9:37034351..37034358,+	p@chr9:37034351..37034358, +
9.66e-127	FFCP PHASE1:Hg19::chr6:32784847..32784854,-	p2@HLA-DOB
9.66e-127	FFCP PHASE2:Hg19::chr6:32784847..32784854,-	p2@HLA-DOB
3.36e-125	FFCP PHASE1:Hg19::chr6:89324022..89324033,-	p@chr6:89324022..89324033, -
3.36e-125	FFCP PHASE2:Hg19::chr6:89324022..89324033,-	p@chr6:89324022..89324033, -
2.02e-124	FFCP PHASE1:Hg19::chr9:37027587..37027596,-	p@chr9:37027587..37027596, -
2.02e-124	FFCP PHASE2:Hg19::chr9:37027587..37027596,-	p@chr9:37027587..37027596, -
3.94e-121	FFCP PHASE2:Hg19::chr16:15733143..15733164,-	p13@KIAA0430
3.94e-121	FFCP PHASE1:Hg19::chr16:15733143..15733164,-	p13@KIAA0430
9.8e-121	FFCP PHASE2:Hg19::chr14:106367355..106367369,-	p@chr14:106367355..106367369, -
9.8e-121	FFCP PHASE1:Hg19::chr14:106367355..106367369,-	p@chr14:106367355..106367369, -
2.95e-119	FFCP PHASE2:Hg19::chr2:89184868..89184885,+	p1@IGKV4-1
2.95e-119	FFCP PHASE1:Hg19::chr2:89184868..89184885,+	p1@IGKV4-1
5.46e-119	FFCP PHASE2:Hg19::chr1:203294429..203294440,+	p@chr1:203294429..203294440, +
5.46e-119	FFCP PHASE1:Hg19::chr1:203294429..203294440,+	p@chr1:203294429..203294440, +
9.11e-119	FFCP PHASE1:Hg19::chr7:120789593..120789628,+	p10@C7orf58
9.11e-119	FFCP PHASE2:Hg19::chr7:120789593..120789628,+	p10@C7orf58
2.42e-118	FFCP PHASE2:Hg19::chr9:95491611..95491638,-	p@chr9:95491611..95491638, -
2.42e-118	FFCP PHASE1:Hg19::chr9:95491611..95491638,-	p@chr9:95491611..95491638, -
1.04e-116	FFCP PHASE2:Hg19::chr14:96181767..96181778,+	p2@ENST00000556386
1.04e-116	FFCP PHASE1:Hg19::chr14:96181767..96181778,+	p2@ENST00000556386
1.03e-115	FFCP PHASE2:Hg19::chr14:96178718..96178752,-	p3@TCL1A
1.03e-115	FFCP PHASE1:Hg19::chr14:96178718..96178752,-	p3@TCL1A
2.11e-113	FFCP PHASE2:Hg19::chr4:102711977..102711978,+	p9@BANK1
2.11e-113	FFCP PHASE1:Hg19::chr4:102711977..102711978,+	p9@BANK1
4.0e-113	FFCP PHASE1:Hg19::chr3:107938341..107938354,-	p9@IFT57
4.0e-113	FFCP PHASE2:Hg19::chr3:107938341..107938354,-	p9@IFT57
7.43e-113	FFCP PHASE2:Hg19::chr14:96178079..96178099,+	p1@ENST00000547644, p1@ENST00000553445
7.43e-113	FFCP PHASE1:Hg19::chr14:96178079..96178099,+	p1@ENST00000547644, p1@ENST00000553445
7.69e-113	FFCP PHASE2:Hg19::chr2:232536651..232536664,+	p@chr2:232536651..232536664, +
7.69e-113	FFCP PHASE1:Hg19::chr2:232536651..232536664,+	p@chr2:232536651..232536664, +
1.43e-112	FFCP PHASE2:Hg19::chr12:111078151..111078169,+	p8@TCTN1
1.43e-112	FFCP PHASE1:Hg19::chr12:111078151..111078169,+	p8@TCTN1
7.03e-112	FFCP PHASE2:Hg19::chr14:53190525..53190534,+	p4@PSMC6
7.03e-112	FFCP PHASE1:Hg19::chr14:53190525..53190534,+	p4@PSMC6
7.03e-112	FFCP PHASE1:Hg19::chr9:37326030..37326040,+	p10@ZCCHC7
7.03e-112	FFCP PHASE2:Hg19::chr9:37326030..37326040,+	p10@ZCCHC7
2.24e-111	FFCP PHASE2:Hg19::chr1:38940657..38940700,+	p2@ENST00000452971
2.24e-111	FFCP PHASE1:Hg19::chr1:38940657..38940700,+	p2@ENST00000452971
3.69e-111	FFCP PHASE1:Hg19::chr17:9955844..9955857,-	p@chr17:9955844..9955857, -
3.69e-111	FFCP PHASE2:Hg19::chr17:9955844..9955857,-	p@chr17:9955844..9955857, -
7.87e-108	FFCP PHASE1:Hg19::chr22:33617765..33617772,-	p2@ENST00000421232
7.87e-108	FFCP PHASE2:Hg19::chr22:33617765..33617772,-	p2@ENST00000421232
1.23e-107	FFCP PHASE2:Hg19::chr22:23260324..23260332,+	p@chr22:23260324..23260332, +
1.23e-107	FFCP PHASE1:Hg19::chr22:23260324..23260332,+	p@chr22:23260324..23260332, +
1.53e-107	FFCP PHASE2:Hg19::chr1:220943806..220943817,+	p@chr1:220943806..220943817, +
1.53e-107	FFCP PHASE1:Hg19::chr1:220943806..220943817,+	p@chr1:220943806..220943817, +
1.92e-107	FFCP PHASE1:Hg19::chr10:49880475..49880487,-	p1@ENST00000440750
1.92e-107	FFCP PHASE2:Hg19::chr10:49880475..49880487,-	p1@ENST00000440750
2.67e-107	FFCP PHASE2:Hg19::chr14:106352840..106352888,-	p@chr14:106352840..106352888, -
2.67e-107	FFCP PHASE1:Hg19::chr14:106352840..106352888,-	p@chr14:106352840..106352888, -
1.83e-106	FFCP PHASE1:Hg19::chr7:22701524..22701535,-	p2@ENST00000442252
1.83e-106	FFCP PHASE2:Hg19::chr7:22701524..22701535,-	p2@ENST00000442252
2.23e-106	FFCP PHASE1:Hg19::chr1:157779174..157779185,-	p@chr1:157779174..157779185, -
2.23e-106	FFCP PHASE2:Hg19::chr1:157779174..157779185,-	p@chr1:157779174..157779185, -
3.68e-106	FFCP PHASE2:Hg19::chr12:32040185..32040200,-	p2@ENST00000535163
3.68e-106	FFCP PHASE1:Hg19::chr12:32040185..32040200,-	p2@ENST00000535163
4.62e-106	FFCP PHASE1:Hg19::chr19:7766976..7766982,-	p9@FCER2
4.62e-106	FFCP PHASE2:Hg19::chr19:7766976..7766982,-	p9@FCER2
8.16e-106	FFCP PHASE2:Hg19::chr3:45637869..45637880,-	p@chr3:45637869..45637880, -
8.16e-106	FFCP PHASE1:Hg19::chr3:45637869..45637880,-	p@chr3:45637869..45637880, -
4.61e-103	FFCP PHASE1:Hg19::chr5:111857189..111857217,+	p1@ENST00000541361
4.61e-103	FFCP PHASE2:Hg19::chr5:111857189..111857217,+	p1@ENST00000541361
6.12e-103	FFCP PHASE2:Hg19::chr2:89145640..89145676,+	p@chr2:89145640..89145676, +
6.12e-103	FFCP PHASE1:Hg19::chr9:35618447..35618456,-	p7@CD72
6.12e-103	FFCP PHASE2:Hg19::chr9:35618447..35618456,-	p7@CD72
6.12e-103	FFCP PHASE1:Hg19::chr2:89145640..89145676,+	p@chr2:89145640..89145676, +
7.75e-103	FFCP PHASE1:Hg19::chr12:111078120..111078129,+	p9@TCTN1
7.75e-103	FFCP PHASE2:Hg19::chr12:111078120..111078129,+	p9@TCTN1
7.43e-102	FFCP PHASE1:Hg19::chr10:97501785..97501801,+	p9@ENTPD1
7.43e-102	FFCP PHASE2:Hg19::chr10:97501785..97501801,+	p9@ENTPD1
1.94e-101	FFCP PHASE1:Hg19::chr3:107938378..107938392,-	p7@IFT57
1.94e-101	FFCP PHASE2:Hg19::chr3:107938378..107938392,-	p7@IFT57
3.28e-101	FFCP PHASE2:Hg19::chr7:148133853..148133864,-	p@chr7:148133853..148133864, -
3.28e-101	FFCP PHASE1:Hg19::chr7:148133853..148133864,-	p@chr7:148133853..148133864, -
6.05e-101	FFCP PHASE1:Hg19::chr18:77220664..77220696,+	p@chr18:77220664..77220696, +
6.05e-101	FFCP PHASE2:Hg19::chr18:77220664..77220696,+	p@chr18:77220664..77220696, +

Showing 1 to 100 of 100 entries